Wat is de prijs voor Poolbeg Pharma PLC (POLB)

Het prijs van Poolbeg Pharma PLC (POLB) is $0.11565963

Wat is de marktkapitalisatie voor Poolbeg Pharma PLC (POLB)

Marktkapitalisatie voorPoolbeg Pharma PLC (POLB) is $882.99K

Poolbeg Pharma PLC (POLB) Prijs en Marktkapitalisatie

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

Prijs voor POLB	Aandeel B	Marktkapitalisatie van B	uitslagen
$713,079 $882.99K	NVDA	$5.444T	+616,532,614.53%
$587,899 $882.99K	AAPL	$4.488T	+508,300,574.19%
$545,318 $882.99K	GOOG	$4.163T	+471,485,262.41%
$485,118 $882.99K	MSFT	$3.704T	+419,435,497.89%
$371,802 $882.99K	AMZN	$2.838T	+321,462,362.08%

Prijs voor POLB

Aandeel B

Marktkapitalisatie van B

uitslagen

$713,079 $882.99K